ABSTRACT The role that the transcription factor OCT4 plays during oocyte growth is yet unknown. In this review, we summarise the data on its potential role in the acquisition of oocyte developmental competence in the mouse. These studies describe the presence in MII oocytes and 2-cell embryos of an OCT4 transcriptional network that might be part of the molecular signature of maternal origin on which the inner cell mass and the embryonic stem cell-associated pluripotency is assembled and shaped. The Oct4-gene regulatory network thus provides a connection between eggs, early preimplantation embryos and embryonic stem cells.
Introduction
The key role played by the transcription factor OCT4 in the maintenance of cell pluripotency is well documented for different cell types, such as primordial germ cells (PGCs), spermatogonia, the blastocyst inner cell mass (ICM) and the epiblast. But also in cell types obtained experimentally, such as embryonal carcinoma cells, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). On the contrary, its presence in the ovary, although reported, remains yet unexplained. Here, we review the data on the presence of OCT4 in the mouse oocyte. Although still scattered, the information obtained thus far indicates a potential role for OCT4 in the acquisition of the oocyte developmental competence and in the establishment of the pluripotency of the ICM.
OCT4 and pluripotency
During preimplantation development, de novo expression of the OCT4 protein is first observed soon after embryonic genome activation, at the 4-8 cell stage, and plays a key role in the establishment of the trophectoderm (TE) and ICM lineages, since down-regulation of its expression is necessary for TE differentiation (Adjaye et al., 2005; Zernicka-Goetz, 2011) . Although heterogeneous levels of expression have been recorded in the different blastomeres throughout preimplantation, its expression level is not predictive of cell lineage patterning (Dietrich et al., 2007) . Instead, the analysis of OCT4 kinetic behaviour (i.e., the biological activity of transcription factors in live cells detected by the fluorescence decay after photoactivation assay) demonstrated that blastomeres with lower OCT4 kinetics are more likely to give rise to the pluripotent cells of the ICM (Plachta et al., 2011) . Down-regulation of OCT4 in the TE cells is accompanied by the down-regulation in the ICM of CDX2, another key factor in the establishment of the two first cell lineages in the preimplantation embryo (Bruce and Zernicka-Goetz, 2010) .
Following implantation, OCT4 is confined to the epiblast and later in development is detected in primordial germ cells (PGCs) (Matsui et al., 1992; Resnik et al., 1992; Goto at al., 1999) , in the adult seminiferous epithelium where its presence is confined to type A spermatogonia (for a review see Dym et al., 2009) , in the primordial and in growing oocytes (Pesce et al., 1998; Adjaye et al., 1999; Zuccotti et al., 2008; ).
OCT4 expression during oocyte growth
Most of our knowledge on the profile of expression of the Oct4 gene and its protein in the oocyte during folliculogenesis has been obtained adopting a model study in which ovarian mouse oocytes are classified into two main groups depending on their chromatin configuration, as observed when cells are stained with the supravital fluorochrome Hoechst 33342. Following staining, an oocyte is classified as surrounded nucleolus (SN), if it possesses a ring of Hoechst-positive heterochromatin around its nucleolus, or as non surrounded nucleolus (NSN) oocyte, if it lacks of this ring and it shows a more dispersed chromatin (Fig. 1) . In 4-6 week-old females, primordial/ primary oocytes with a diameter of 10-20 mm and the following growing phases up to a size of 40 mm, own an NSN-type of chromatin organisation. Then, at the time of follicle recruitment (41-50 mm) about 5% of oocytes acquire the SN-type of chromatin configuration; a number that increases with growth, reaching a frequency of about 50% in fully-grown antral oocytes (Zuccotti et al., 1995) . An important feature of this model study is that when fully-grown antral SN oocytes are isolated from the ovary, cultured in vitro to the MII stage and inseminated, they complete preimplantation (Zuccotti et al., 1998; 2002) and full-term (Inoue et al., 2008) development; on the contrary, fully-grown NSN oocytes, although the number of transcripts increases from primordial/primary oocytes (10-20 mm) to antral oocytes of 61-70 mm and then it decreases in fully-grown and MII oocytes. Instead, the expression pattern of the OCT4 protein during oocyte growth shows a marked difference in the two types of oocytes. OCT4 is expressed in primordial/primary oocytes (10-20 mm), and then it is down-regulated in oocytes of 21-40 mm and reappears again, but only in SN oocytes, when follicles are recruited to begin their growth (Pesce et al., 1998; Zuccotti et al., 2009) . The profile of expression of this transcription factor remains confined to the SNtype of chromatin configuration also during the following maturation phases up to the fully-grown stage and to the derived developmentally competent MII SN oocyte, whereas it is down-regulated in developmentally incompetent MII NSN oocytes (Zuccotti et al., 2009) (Fig. 2) .
As already demonstrated for ESCs (Boyer et al., 2005; Loh et al., 2006; Babaie et al., 2007) , the down-regulation of OCT4 in MII NSN oocytes affects, directly or indirectly, the profile of expression of numerous genes, including specific known OCT4-regulated genes. In ESCs the OCT4 transcription factor binds directly to the Nanog locus regulating the expression of a number of pluripotency genes therein, such as Nanog, Stella (also know as Dppa3), Apobec1, Gdf3 and Foxj2 (Levasseur et al., 2008) . Analogously, from the time of follicle recruitment and during the following oocyte growth, upregulation of OCT4 is paralleled by the up-regulation of the STELLA protein in SN oocytes, whereas its down-regulation corresponds to STELLA down-regulation in ovarian NSN and in their derived NSN antral oocytes arrest development at the 2-cell stage. The presence of these two types of oocytes has been observed in most of the mammalian species studied: in rats (Mandl and Zuckerman, 1952) , bovine (Lodde et al., 2008) , monkeys (Lefe`vre et al., 1989) , pigs (Crozet, 1983) and humans (Parfenov et al., 1989) . Only goat (Sui et al., 2005) and equine (Hinrichs and Williams, 1997) oocytes seem to represent exceptions, as their germinal vesicles do not show the SN type of chromatin configuration (for a review see Tan et al., 2009) .
In the adult mouse ovary, Oct4 transcripts are present throughout folliculogenesis without significant differences between SN and OCT4 and oocyte developmental competence 855 MII NSN oocytes (Zuccotti et al., 2009) . Furthermore, as observed in ESCs, the expression of Foxj2 in developmentally incompetent MII NSN oocytes is up-regulated in the absence of OCT4; whereas Foxj2 is down-regulated in the presence of OCT4 in developmentally competent MII SN oocytes (Zuccotti et al., 2009 ). Both STELLA and Foxj2 play an important role in preimplantation development. STELLA, the best known, is a maternal-effect factor required at the 1-cell stage to protect against demethylation of the maternal genome and of some paternal imprinted genes (Nakamura et al., 2007) ; its lack of expression leads to a developmental arrest mainly at the 2-cell stage (Payer et al., 2003) . Furthermore, Foxj2 up-regulation leads to a developmental block at the 2-cell stage (Martin-de-Lara et al., 2008) .
Although a direct function of OCT4 on the Nanog locus in oocytes as not been yet proved, the observed behaviour analogies of OCT4 in ESCs and oocytes indicate the centrality of this interaction in the acquisition of the oocyte developmental competence and suggest, in this respect, the need for further investigations.
Effects of the down-regulation of OCT4 on the oocyte transcriptome
Whilst the expression of other maternal-effect genes (i.e., Npm2, Zar1, Smarca4 and Prei3) does not appear to be affected, as they are equally expressed in MII SN and MII NSN oocytes (Zuccotti et al., 2008) (Fig.  3) (Zuccotti et al., 2011) . Gene onthology enrichment analysis of the function of these 197 genes assigned them to several major biological processes, including pluripotency, chromatin organisation, apoptosis, subcortical maternal complex, transcription factorscancer, translation-cancer, oxidative phosphorylation, porphyrin metabolism, anion exchange, TGF-b signalling, copper distribution, regulation of transcription, protein phosphorilation, cell cycle, protein assembly and signal transduction (Fig. 4) .
The group of 80 genes that operates in MII oocytes and includes known OCT4-regulated genes (from now on named Oct4 transcriptional network, Oct4-TN), survives the massive transcriptional erasure that occurs following fertilisation (Li et al., 2010) and is expressed in 2-cell embryos. Most genes of the Oct4-TN are expressed in cancer cells and 37 are known partners of the Oct4 transcriptome in ESCs (Boyer et al., 2005; Loh et al., 2006; Babaie et al., 2007) (Fig. 5) . Interestingly, the majority of these genes are down-regulated in MII ctrl oocytes, whereas after fertilisation, the same genes result up-regulated in 2-cell ctrl embryos, an expression behaviour that is confirmed by the immunoanalysis of the proteins of two of these genes (DNMT3L and RSP20; Zuccotti et al., 2011) .
Among the biological processes that emerge in the Oct4-TN in MII oocytes, two are worth a particular mention for the role that they play in developmental processes. The proteins of the maternaleffect genes Mater, Tle6, Ooep and Filia belong to the subcortical maternal complex (Fig. 4) (Li et al., 2008) , they are located in the subcortex of MII oocytes and required for zygotes to progress beyond the first embryonic cell divisions of preimplantation mouse development. During cleavage, these proteins are excluded from regions of blastomere-blastomere contact and segregate to the outer cells of the morula and blastocyst embryo during the TE/ ICM differentiation. Another group of 'pluripotency'-associated genes includes Dppa4, Sall4, Klf4 and Sox2, the latter two being well-known OCT4 companions in the maintenance of self-renewal and pluripotency in ESCs and their over-expression together with that of Oct4 and c-Myc induces dedifferentiation of terminally differentiated somatic cells (e.g., fibroblasts) and the formation of iPSCs (Yamanaka, 2007) .
Further perspectives and experiments
Even though the results of these studies do not provide a definitive answer as to the precise function played by OCT4 in folliculogenesis, they reveal a number of evidences of a correlation between OCT4 and the oocyte developmental competence and of a relationship between this transcription factor and a number of genes that are present also in the OCT4 gene regulatory network operative in ESCs. These data indicate that Oct4-TN might be part of the molecular signature of maternal origin on which the ESCs molecular identity is assembled and shaped, thus providing a connection between eggs, early preimplantation embryos and ESCs.
Future experiments ought now to describe the transcriptional and translational behaviour of the Oct4-TN genes during oocyte growth and preimplantation development, up to the implanting blastocyst, when differentiation of the TE and ICM cell lines occurs (Fig. 6) . Also, inactivation of the Oct4 gene expression (e.g., by RNAi or morpholino injection into the oocyte) at the time of follicle recruitment, would give a more precise picture of the molecular function played by OCT4 within this developmental context.
